Balance is key no doubt. If you do that on a stock BB you’ll get the wrath of the Kool Aid drinkers or just get labeled a FUDD or short position.
The science of LL is sound, it’s the biz/drug development that is in play. Doesn’t matter what we say here unless it’s gets implemented by the board/CEO.
The above is just common sense, but it has to be said daily on most BBs. If played correctly with a strong tailwind the sky is the limit on market cap. Imagine being Usain bolt at a high school track meet.... there’s still ways to lose this.